Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01332968||Active, not recruiting
|A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)||
||Industry / Other||
||1401||All||18 Years and older (Adult, Older Adult)||NCT01332968||BO21223
|July 6, 2011||February 1, 2016||April 8, 2021||April 11, 2011||October 1, 2019||June 7, 2017||